NeuroOne Medical Technologies/$NMTC
1D1W1MYTD1Y5YMAX
Capital at risk
About NeuroOne Medical Technologies
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
- Ticker
- $NMTC
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 18
- Headquarters
- Eden Prairie, United States
- Website
- nmtc1.com
NMTC Metrics
BasicAdvanced
$13M
-
-$0.95
0.64
-
Price and volume
Market cap
$13M
Beta
0.64
52-week high
$5.40
52-week low
$1.38
Average daily volume
568K
Financial strength
Current ratio
2.836
Quick ratio
1.541
Long term debt to equity
0.019
Total debt to equity
0.047
Profitability
EBITDA (TTM)
-7.663
Gross margin (TTM)
23.00%
Net profit margin (TTM)
-59.71%
Operating margin (TTM)
-63.36%
Revenue per employee (TTM)
$690,000
Management effectiveness
Return on assets (TTM)
-58.07%
Return on equity (TTM)
-124.66%
Valuation
Price to revenue (TTM)
0.958
Price to book
3.26
Price to tangible book (TTM)
3.28
Price to free cash flow (TTM)
-1.668
Free cash flow yield (TTM)
-59.97%
Free cash flow per share (TTM)
-0.846
Growth
Revenue change (TTM)
88.09%
Earnings per share change (TTM)
4.53%
3-year revenue growth (CAGR)
38.66%
3-year earnings per share growth (CAGR)
-36.06%
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.